I. Gilloteau

1.3k citations
48 papers · 998 indexed · h-index 18
Topics
Psoriasis: Treatment and Pathogenesis (29 papers)Dermatology and Skin Diseases (16 papers)Spondyloarthritis Studies and Treatments (10 papers)

In The Last Decade

I. Gilloteau

48 papers receiving 971 citations

Peers

I. Gilloteau
Comparison fields: 5 of 77
  • Immunology 504
  • Dermatology 302
  • Oncology 200
  • Economics and Econometrics 172
  • Rheumatology 169
Replace Erica D. Dommasch with:
Erica D. Dommasch United States
Vivian Herrera United States
Kathleen McElhone United Kingdom
K Malottki United Kingdom
Ahmed M. Soliman United States
Richard Shames United States
Brian Calimlim United States
Liza Takiya United States
Debra Kennedy Australia
Bruno Émond United States
I. Gilloteau relative to Erica D. Dommasch United States Erica D. Dommasch's profile →
Citations per field
00.5×3.8×
Erica D. Dommasch · 1×
Citations per year

Countries citing papers authored by I. Gilloteau

Since Specialization
Citations

This map shows the geographic impact of I. Gilloteau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Gilloteau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Gilloteau more than expected).

Fields of papers citing papers by I. Gilloteau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Gilloteau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Gilloteau. The network helps show where I. Gilloteau may publish in the future.

Co-authorship network of co-authors of I. Gilloteau

This figure shows the co-authorship network connecting the top 25 collaborators of I. Gilloteau. A scholar is included among the top collaborators of I. Gilloteau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Gilloteau. I. Gilloteau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 4
3 11
4 22
5 1
6 65
7 9
8 1
9 1
10 44
11 1
12 19
13 4
14 89
15 7
16 29
17 132
18 1
19 89
20 3

About I. Gilloteau

I. Gilloteau is a scholar working on Dermatology, Immunology and Rheumatology, having authored 48 papers that have together received 998 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (29 papers), Dermatology and Skin Diseases (16 papers) and Spondyloarthritis Studies and Treatments (10 papers). The work is most often cited by research in Dermatology (302 citations), Immunology (504 citations) and Hematology (160 citations). I. Gilloteau has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Amir Goren, Marco DiBonaventura, Michael Lees, Matthias Augustin, Kristien Van der Elst, René Westhovens, Michelle Tran, Steven R. Feldman, Hongqing Tian and C. Papavassilis. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026